World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
84
Citations
26492
World Ranking
919
National Ranking
425

Medicine

D-Index
86
Citations
29372
World Ranking
14058
National Ranking
7130

Gregory D. Kirk publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Gregory D. Kirk sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 296 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Gregory D. Kirk D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Gregory D. Kirk sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 84 D-Index — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Gregory D. Kirk is affiliated with Johns Hopkins University in the United States. Their research primarily focuses on medicine, with extensive work in epidemiology, infectious diseases, hepatology, emergency medicine, and public health, environmental and occupational health.

The scientist's recent papers cover a range of topics within infectious diseases and related fields. Notable publications include:

  • Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US, 2021, JAMA Internal Medicine
  • Weight gain among treatment-naïve persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada, 2020, Journal of the International AIDS Society
  • Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data, 2021, The Lancet HIV
  • Detecting Liver Cancer Using Cell-Free DNA Fragmentomes, 2022, Cancer Discovery
  • Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial, 2021, The Lancet Neurology

The scientist frequently collaborates with a set of known coauthors who have contributed to a significant number of publications, including Shruti H. Mehta (76 publications), Richard D. Moore (52 publications), Becky L. Genberg (36 publications), Mari M. Kitahata (34 publications), and Keri N. Althoff (33 publications).

Gregory D. Kirk's work has been published across several notable venues, reflecting their focus areas. These include UNC Libraries, Drug and Alcohol Dependence, The Journal of Infectious Diseases, bioRxiv (Cold Spring Harbor Laboratory), and Clinical Infectious Diseases.

The scientist's research spans numerous topics in the field of medicine, with a substantial concentration on HIV and associated conditions. Key topics in their research portfolio include:

  • HIV, Drug Use, Sexual Risk
  • HIV/AIDS Research and Interventions
  • HIV-related health complications and treatments
  • Hepatitis C virus research
  • Hepatitis B Virus Studies
  • Liver Disease Diagnosis and Treatment
  • Opioid Use Disorder Treatment

Best Publications

  • Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

    David L. Thomas;Chloe L Thio;Maureen P. Martin;Ying Qi

  • Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada.

    Hasina Samji;Angela Cescon;Robert S. Hogg;Robert S. Hogg;Sharada P. Modur

  • Effect of early versus deferred antiretroviral therapy for HIV on survival.

    Mari M. Kitahata;Stephen J. Gange;Alison G. Abraham;Barry Merriman

  • Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1

    Maureen P. Martin;Ying Qi;Xiaojiang Gao;Eriko Yamada

  • Short Physical Performance Battery and all-cause mortality: systematic review and meta-analysis

    Rita Pavasini;Jack M. Guralnik;Justin C. Brown;Mauro Di Bari

  • A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals.

    Meredith S. Shiels;Stephen R Cole;Gregory D. Kirk;Charles L Poole

  • Risk of Anal Cancer in HIV-Infected and HIV-Uninfected Individuals in North America

    Michael J. Silverberg;Bryan Lau;Amy C. Justice;Amy C. Justice;Eric Engels

  • HIV Infection Is Associated with an Increased Risk for Lung Cancer, Independent of Smoking

    Gregory D. Kirk;Christian Merlo;Peter O'Driscoll;Shruti H. Mehta

  • Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US.

    Unknown

  • Influence of HLA-C Expression Level on HIV Control

    Richard Apps;Richard Apps;Ying Qi;Ying Qi;Jonathan M. Carlson;Haoyan Chen;Haoyan Chen

  • Limited Uptake of Hepatitis C Treatment Among Injection Drug Users

    Shruti H. Mehta;Becky L. Genberg;Jacquie Astemborski;Ravi Kavasery

  • Human Immunodeficiency Virus-Related Microbial Translocation and Progression of Hepatitis C

    Ashwin Balagopal;Frances H. Philp;Jacquie Astemborski;Timothy M. Block

  • Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study

    Michael J. Silverberg;Bryan Lau;Chad J. Achenbach;Yuezhou Jing

  • HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C

    Rasmi Thomas;Richard Apps;Ying Qi;Xiaojiang Gao

  • Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study.

    Alison G. Abraham;Gypsyamber D'Souza;Yuezhou Jing;Stephen J. Gange

  • Late Presentation for Human Immunodeficiency Virus Care in the United States and Canada

    Keri N. Althoff;Stephen J. Gange;Marina B. Klein;John T. Brooks

  • Cohort Profile: The North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD)

    Stephen J Gange;Mari M Kitahata;Michael S Saag;David R Bangsberg

  • Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from The Gambia.

    Gregory D. Kirk;Anne Marie Camus-Randon;Maimuna Mendy;James J. Goedert

  • The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa.

    Gregory D. Kirk;Gregory D. Kirk;Olufunmilayo A. Lesi;Olufunmilayo A. Lesi;Maimuna Mendy;Aliu O. Akano

  • Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts

    Priya Duggal;Chloe L. Thio;Genevieve L. Wojcik;James J. Goedert

  • HIV, Age, and the Severity of Hepatitis C Virus–Related Liver Disease

    Gregory D. Kirk;Shruti H. Mehta;Jacquie Astemborski;Noya Galai

Frequent Co-Authors

Shruti H. Mehta
Shruti H. Mehta Johns Hopkins University
James J. Goedert
James J. Goedert National Institutes of Health
Jacquie Astemborski
Jacquie Astemborski Johns Hopkins University
David L. Thomas
David L. Thomas Johns Hopkins University
Richard D. Moore
Richard D. Moore Johns Hopkins University
Thomas C. Quinn
Thomas C. Quinn Johns Hopkins University
Oliver Laeyendecker
Oliver Laeyendecker Johns Hopkins University
Susan Buchbinder
Susan Buchbinder University of California, San Francisco
Timothy R. Sterling
Timothy R. Sterling Vanderbilt University Medical Center
Chloe L. Thio
Chloe L. Thio Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying microbiology opens doors to various interdisciplinary career paths, especially in healthcare and data management. For those interested in clinical roles, programs like functional medicine nurse practitioner programs offer specialized training that combines microbiological knowledge with patient care. This path emphasizes a holistic approach to diagnosing and treating illness, making it a dynamic option for microbiology graduates.

Another promising avenue is health information management. Understanding microbiology can enhance cellular-level insights useful for managing electronic health records and patient data. Pursuing an accredited online health information management degree CAHIIM ensures students gain the credentials needed to excel in this growing field.

After obtaining a relevant degree, certification like becoming a certified professional coder can elevate your profile by enabling you to accurately code medical records, a critical task within healthcare systems. This certification often leads to strong job prospects and competitive salaries.

For those targeting management roles, exploring the career of a health information manager salary can provide insights into the financial benefits and responsibilities in overseeing health data organizations. This mix of science and administration is ideal for microbiology graduates eager to influence healthcare outcomes on a broader scale.

Best Scientists Citing Gregory D. Kirk

Trending Scientists

Recently Published Articles